000 | 03433nam a22003974a 4500 | ||
---|---|---|---|
999 |
_c12934 _d12934 |
||
001 | 58526990 | ||
003 | OCoLC | ||
005 | 20211001065237.0 | ||
008 | 050222s2005 paua b 001 0 eng | ||
010 | _a2005271849 | ||
020 | _a0323032869 | ||
035 | _a.b2452864x | ||
040 |
_aDLC _cDLC _dSBH _dVAM _dNLM _dMBB _dIXA _dBAKER |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRM300 _b.H86 2005 |
060 | 0 | 0 | _a2005 E-843 |
060 | 1 | 0 |
_aQV 4 _bH918 2005 |
082 | 0 | 0 |
_a615.58 _222 |
100 | _a Minneman Kenneth P. | ||
245 | 0 | 0 |
_aBrody's human pharmacology : _bmolecular to clinical / _ceditors, Kenneth P. Minneman, Lynn Wecker ; consulting editors, Joseph Larner, Theodrore M. Brody |
246 | 3 | 0 | _aHuman pharmacology |
250 | _a4th ed | ||
260 |
_aPhiladelphia, Pa. : _bElsvier Mosby, _cc2005 |
||
300 |
_axvii, 775 p. : _bcol. ill. ; _c28 cm |
||
504 | _aIncludes bibliographical references and index | ||
505 | 0 | _aIntroduction and definitions -- Receptors and concentration-response relationships -- Absorption, distribution, metabolism, and elimination -- Clinical pharmacokinetics and issues in therapeutics -- Gene therapy and emerging molecular therapies -- Regulated drug development and usage -- Herbals and natural products -- Introduction to the autonomic nervous system -- Drugs affecting the parasympathetic nervous system and autonomic ganglia -- Drugs affecting the sympathetic nervous system -- Regulation of blood pressure by the autonomic nervous system -- Antihypertensive drugs -- Diuretics: drugs that increase the excretion of water and electrolytes -- Antiarrhythmic drugs -- Drugs to treat heart failure -- Vasodilators and nitric oxide synthase -- Prostaglandins and related autacoids -- Lipid-lowering drugs and atherosclerosis -- Drugs to treat blood disorders -- Introduction to the central nervous system -- Treatment of Parkinson's and Alzheimer's diseases -- Treatment of psychotic disorders -- Treatment of affective disorders -- Treatment of anxiety and sleep disorders -- Ethanol and related compounds -- Treatment of eating disorders and obesity -- Treatment of seizure disorders --General anesthetics -- Skeletal muscle relaxants -- Local anesthetics --Drugs to control pain -- Drug and substance abuse -- Glucocorticoids and mineralocorticoids -- Drugs to treat asthma and chronic obstructive pulmonary disease -- Estrogens and progestins -- Androgens and antiandrogens -- Thyroid and antithyroid drugs -- Insulin and drugs used in the therapy of diabetes mellitus -- Drugs affecting utrerine motility -- Hypothalamic-pituitary hormones -- Calcium-regulating hormones and other agents affecting bone -- Mechanisms of action of antineoplastic drugs -- Clinical effects of antineoplastic drugs -- Principles of antimicrobial use -- Bacterial cell wall inhibitors -- Inhibitors of bacterial ribosomal actions -- Bacterial folate antagonists, fluoroquinolones, and other antibacterial agents -- Selection of an antibacterial agent -- Antimycobacterial agents -- Antifungal agents -- Antiviral agents -- Drugs to treat parasitic infections -- Immunopharmacology -- Histamines and antihistamines -- Gastrointestinal drugs -- Toxicology | |
600 | _2pharmacology | ||
650 | 0 | _aPharmacology | |
650 | 0 | _aChemotherapy | |
650 | 1 | 2 | _aPharmacology |
650 | 2 | 2 | _aDrug Therapy |
700 | 1 | _aBrody, Theodore M | |
700 | 1 |
_aLarner, Joseph, _d1921- |
|
700 | 1 | _aMinneman, Kenneth P | |
942 |
_2ddc _cBK |